The role of axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases.

[1]  D. Landsittel,et al.  Sentinel Lymph Node Micrometastasis as a Predictor of Axillary Tumor Burden , 2004, The breast journal.

[2]  Guido Nicolò,et al.  Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients , 2004, Journal of surgical oncology.

[3]  Umberto Veronesi,et al.  A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. , 2003, The New England journal of medicine.

[4]  T. H. van der Kwast,et al.  Non-sentinel lymph node involvement in patients with breast cancer and sentinel node micrometastasis; too early to abandon axillary clearance , 2002, Journal of clinical pathology.

[5]  P. Querzoli,et al.  Prognostic and Therapeutic Impact of Sentinel Node Micrometastasis in Patients with Invasive Breast Cancer , 2002, Tumori.

[6]  T. Nims,et al.  Is a completion axillary dissection indicated for micrometastases in the sentinel lymph node? , 2001, American journal of surgery.

[7]  A. Luini,et al.  Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma , 2001, Cancer.

[8]  H. Cody,et al.  Lymphovascular Invasion Enhances the Prediction of Non-Sentinel Node Metastases in Breast Cancer Patients With Positive Sentinel Nodes , 2001, Annals of Surgical Oncology.

[9]  I. Ellis,et al.  Pathological validation and significance of micrometastasis in sentinel nodes in primary breast cancer , 2001, Breast Cancer Research.

[10]  A. Giuliano,et al.  Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node , 2000, Cancer.

[11]  S. Ménard,et al.  Breast cancer patients treated without axillary surgery: clinical implications and biologic analysis. , 2000, Annals of surgery.

[12]  A. Cantor,et al.  Do Cytokeratin-Positive-Only Sentinel Lymph Nodes Warrant Complete Axillary Lymph Node Dissection in Patients with Invasive Breast Cancer? , 2000, The American surgeon.

[13]  C. Miller,et al.  Meta-analysis of sentinel lymph node biopsy in breast cancer. , 1999, The Journal of surgical research.

[14]  J. Donohue,et al.  Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  A E Giuliano,et al.  Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? , 1999, Annals of surgery.

[16]  J. Zujewski,et al.  The 1998 St. Gallen's Consensus Conference: an assessment. , 1998, Journal of the National Cancer Institute.

[17]  S. Edge,et al.  Sentinel node biopsy in breast cancer , 1998, Annals of Surgical Oncology.

[18]  P. V. van Diest,et al.  Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. , 1998, Journal of the American College of Surgeons.

[19]  M. Fan,et al.  Lymph node micrometastases from breast carcinoma , 1997, Cancer.

[20]  Umberto Veronesi,et al.  Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes , 1997, The Lancet.

[21]  A. Giuliano.  Guest editorial: Sentinel lymphadenectomy in primary breast carcinoma: An alternative to routine axillary dissection , 1996, Journal of surgical oncology.

[22]  R. Gelber,et al.  Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. , 1995, Journal of the National Cancer Institute.

[23]  S. Shousha,et al.  Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. , 1994, Cancer research.

[24]  Internationalludwigbreastcanc.  Prognostic importance of occult axillary lymph node micrometastases from breast cancers , 1990 .

[25]  C. Carter,et al.  Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases , 1989, Cancer.

[26]  B Fisher,et al.  Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. , 1985, The New England journal of medicine.

[27]  D. Cox,et al.  The analysis of binary data , 1971 .

[28]  R. Hutter,et al.  Significance of Axillary Macrometastases and Micrometastases in Mammary Cancer , 1971, Annals of surgery.

[29]  F. Greene.  AJCC cancer staging handbook , 2002 .

[30]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.

[31]  R. Orr.  The Impact of Prophylactic Axillary Node Dissection on Breast Cancer Survival—A Bayesian Meta-Analysis , 1999, Annals of surgical oncology.

[32]  Early Breast Cancer Trialists' Collaborative Group.  Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group. , 1992, Lancet.